Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-2618
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies ; volume:6 ; number:1 ; day:22 ; month:5 ; year:2018 ; pages:1-13 ; date:12.2018
Microbiome ; 6, Heft 1 (22.5.2018), 1-13, 12.2018
- Creator
-
Panebianco, Concetta
- Contributor
-
Andriulli, Angelo
Pazienza, Valerio
SpringerLink (Online service)
- DOI
-
10.1186/s40168-018-0483-7
- URN
-
urn:nbn:de:101:1-2018080300513703402304
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Panebianco, Concetta
- Andriulli, Angelo
- Pazienza, Valerio
- SpringerLink (Online service)
Other Objects (12)
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Spaceflight alters host-gut microbiota interactions
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Spaceflight alters host-gut microbiota interactions
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Clinical development of targeted and immune based anti-cancer therapies
Exploiting replication deficiencies to illuminate HIV: host interactions
Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Erratum to: miRNAs: micro-managers of anticancer combination therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies